Fundraising FoxVascular Pharmaceuticals
Chapel Hill, US · Delaware corporation · 1 known investors
Find your way into Vascular Pharmaceuticals
Sign up to see every warm intro you have to Vascular Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Vascular Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Vascular Pharmaceuticals develops VPI-2960B, a therapeutic candidate in clinical development for diabetic nephropathy treatment. The company focuses on advancing this potential breakthrough therapy through Phase 2 trials.
Founders & leadership
Board
Investors · 1
How we know: the company's own site · funding news · Not right? Tell us
Funding
SEC filings, press & company announcements$18.1M disclosed across 2 of 3 rounds · 2012–2015
- Undisclosed amountSeries AMar 2015Source ↗
▶$3MraisedJan 2016 · 6 investors · BiotechnologyRule 506(b)
- Benjamin RovinskiDirector
- Elizabeth StonerDirector
- David ClemmonsDirector
- Richard SheaExecutive Officer, Director
- Bonnie LaymanExecutive Officer
- Richard KentDirector
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15.1MraisedFeb 2015 · 6 investors · BiotechnologyRule 506(b)
- David ClemmonsDirector
- Richard SheaExecutive Officer, Director
- Richard KentDirector
- Elizabeth StonerDirector
- Bonnie LaymanExecutive Officer
- Offering amount
- $25.1M
- Amount sold
- $15.1M
- First sale
- Sep 2012
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Vascular Pharmaceuticals went on to found or lead other companies.
Related companies · 2
Companies working in the same space as Vascular Pharmaceuticals.
In the news
Frequently asked questions
- What does Vascular Pharmaceuticals do?
- Vascular Pharmaceuticals develops VPI-2960B, a therapeutic candidate in clinical development for diabetic nephropathy treatment. The company focuses on advancing this potential breakthrough therapy through Phase 2 trials.
- Who founded Vascular Pharmaceuticals?
- Vascular Pharmaceuticals was founded by Laura Maile.
- Who are Vascular Pharmaceuticals's investors?
- Vascular Pharmaceuticals's investors include MPM BioImpact.
- How much funding has Vascular Pharmaceuticals raised?
- Vascular Pharmaceuticals has disclosed $18.1M raised across 2 of its 3 known rounds.
- Where is Vascular Pharmaceuticals headquartered?
- Vascular Pharmaceuticals is headquartered in Chapel Hill, US.